Cepheid (CPHD) Reports Q4 EPS of 7c, Offers FY16 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- S&P 500, Dow set for lower open after jobs report fuels rate-hike bets
- US nonfarm payrolls surge in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil heads for weekly gain as US-Iran fighting resumes; diesel hits record high
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Leerink Partners Reiterates Market Perform on Cepheid (CPHD) Following 4Q
February 3, 2016 8:51 AM ESTLeerink Partners reiterated a Market Perform rating on Cepheid (NASDAQ: CPHD), and cut the price target to $33.00 (from $39.00), following the company's 4Q earnings report. CPHDs reported revenue of $147M was in-line with the Street's forecast of $147M. Higher-than-consensus clinical systems sales were offset... More
